Announcement under Regulation 30 (LODR)-Press Release / Media Release
press release for unaudited financial results for the quarter / half year ended 30th September 201831-10-2018
Announcement under Regulation 30 (LODR)-Press Release / Media Release
press release for unaudited financial results for the quarter / half year ended 30th September 2018Unaudited Financial Results For The Quarter And Half Year Ended 30Th Sept 2018
Unaudited Financial Results for the quarter and half year ended 30th Sept 2018Board Meeting Intimation for To Approve Unaudited Quarterly Financial Results For The Quarter Ended 30Th Sep 2018
NATH BIO-GENES (INDIA) LTDhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/10/2018 ,inter alia, to consider and approve Unaudited Quarterly Financial Results for the Quarter ended 30th Sep 2018Compliance Under Section 40 Of SEBI (LODR)2015
Compliance under Section 40 of SEBI (LODR)2015Shareholding for the Period Ended September 30, 2018
Nath Bio-Genes (India) Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2018. For more details, kindly Click hereCompliance Certificate For The Period Ended 30Th Sept 2018
Compliance Certificate for the period ended 30th Sept 2018Statement Of Investor Complaints For The Quarter Ended September 2018
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0110 Name of the Signatory :- DHIRAJ RATHIDesignation :- Company Secretary and Compliance OfficerAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Analyst/Investor MeetAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Analysts''/investors Meet